Results for ipersensittivita translation from Maltese to English

ipersensittivita’ għad-dawl
hypersensitivity to light

ipersensittivita’ li tinkludi anġjoedema
hypersensitivity, including angioedema

reazzjonijiet allerġiċi serji (ipersensittivita).
serious allergic (hypersensitivity) reactions.

ipersensittivita’ li tinkludi urtikarja u anġjoedema
hypersensitivity including urticaria and angioedema

ipersensittivita` (inkluż anġjoedima u anafillassi)
hypersensitivity (including angioedema and anaphylaxis)

ipersensittivita' (li jinkludi anġjoedema u anafilassi)
hypersensitivity (including angioedema and anaphylaxis)

tinnota ipersensittivita’ eċċessiva jew reazzjonijiet allerġiċi, bħal anafilassi.
notice serious hypersensitivity or allergic reactions, such as anaphylaxis.

ipersensittivita` inklużi reazzjoni anafilattika u xokk, inklużi rapporti b’eżitu fatali
hypersensitivity, including anaphylactic reaction and shock, including reports with fatal outcome

ipersensittivita’ wara tilqim li jkun ingħata qabel għal-epatite a u/jew epatite b.
hypersensitivity after previous administration of hepatitis a and/or hepatitis b vaccines.

ipersensittivita ’ għas- sustanzi attivi jew għal xi wieħed mis- sustanzi mhux attivi jew neomycin.
hypersensitivity to the active substances or to any of the excipients or neomycin.

sodium metabisulphite (e223) jista’ jikkawża reazzjonijiet severi ta’ ipersensittivita` u bronkospażmu.
sodium metabisulphite (e223) may rarely cause severe hypersensitivity reactions and bronchospasm.

sodium metabisulphite (e223) rarament tista’ tikkawża reazzjonijiet severi ta’ ipersensittivita` u bronkospażmu.
sodium metabisulphite (e223) may rarely cause severe hypersensitivity reactions and bronchospasm.

sodium metabisulphite (e223), sustanza jista’ jikkawża reazzjonijiet severi ta’ ipersensittivita` u bronkospażmu.
sodium metabisulphite (e223) may rarely cause severe hypersensitivity reactions and bronchospasm.

f'każijiet rari ħafna rejazzjonijiet ta' ipersensittivita immedjadti e.g. remettar, qtugħ ta' nifs u xokk jistgħu jseħħu.
in very rare cases other immediate hypersensitivity reactions, e.g. vomiting, dyspnoea and shock, may occur.

mard simili għall- influwenza, għeja, tbenġil jew telf ta ’ demm fis- sit ta ’ l - injezzjoni (inkluża reazzjoni ta ’ ipersensittivita fis- sit ta ’ l- injezzjoni), reazzjoni fis- sit ta ’ l- injezzjoni, ipertrofija fis- sit ta ’ l- injezzjoni (eż. lipoipertrofija) *
and administration site conditions: influenza-like illness, fatigue, injection site bruising or bleeding, injection site reaction (including injection site hypersensitivity), injection site hypertrophy (e. g. lipohypertrophy)*